PAR 0.00% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-337

  1. 4,376 Posts.
    lightbulb Created with Sketch. 6924
    Happell, yep true, there is a 51cap article that has a picture of the bio-signatures of iPPS compared with other’s failed attempts, I’m assuming it’s a mass spectrometry comparison and FDA needs it to be an exact match, a very difficult job to do with literally millions of combinations as a result of a 150+ step manufacturing process, we are fine in this area at least!

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.